MedTech Dive October 16, 2024
Elise Reuter

Canada’s device agency plans to issue guidance on machine learning, and the FDA plans to release a draft guidance next year on lifecycle management and premarket submissions for AI devices.

TORONTO — Medical device regulators from the U.S. and Canada addressed one of the industry’s buzziest topics Tuesday at Advamed’s The MedTech Conference: artificial intelligence.

The Food and Drug Administration has authorized nearly 1,000 AI-enabled medical devices, and Health Canada has authorized hundreds. But there are still several unanswered questions about the technology, including how to monitor the performance of algorithms that can adapt over time and how to regulate generative AI tools.

FDA and Health Canada regulators shared their thoughts about these challenges and provided a glimpse at...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Regulations, Technology
Is Apple Intelligence the new Apple Maps?
Headways and hurdles: How AI is shaping the future of medicine
Overhyped: Manus From Monica — AI Made In China
Silicon Valley Startup Inception Labs Creates Faster LLM
AI model uses ECGs to detect females at high risk of heart disease

Share This Article